EP2139777A1 - Emballage pour la stérilisation par uv - Google Patents

Emballage pour la stérilisation par uv

Info

Publication number
EP2139777A1
EP2139777A1 EP08716505A EP08716505A EP2139777A1 EP 2139777 A1 EP2139777 A1 EP 2139777A1 EP 08716505 A EP08716505 A EP 08716505A EP 08716505 A EP08716505 A EP 08716505A EP 2139777 A1 EP2139777 A1 EP 2139777A1
Authority
EP
European Patent Office
Prior art keywords
packaging
product
film
sterilization
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP08716505A
Other languages
German (de)
English (en)
Other versions
EP2139777B1 (fr
Inventor
Detlef Busch
Dirk Walgenbach
Bertram Schmitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Treofan Germany GmbH and Co KG
Original Assignee
Treofan Germany GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Treofan Germany GmbH and Co KG filed Critical Treofan Germany GmbH and Co KG
Publication of EP2139777A1 publication Critical patent/EP2139777A1/fr
Application granted granted Critical
Publication of EP2139777B1 publication Critical patent/EP2139777B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/12—Sterilising contents prior to, or during, packaging
    • B65B55/16—Sterilising contents prior to, or during, packaging by irradiation

Definitions

  • the invention relates to a packaging with food and / or utensils that are sterilized or sanitized for hygienic reasons.
  • the invention also relates to a process for the sterilization, sterilization or partial sterilization of packaged goods.
  • a UV treatment of the washing and Transport water with which the food is pre-cleaned is required.
  • an additional UV treatment of the product to be packaged is required.
  • the different foods or goods pass through an area in which they are exposed to the UV radiation for a certain period of time in order to achieve a certain rate of sterilization.
  • the goal is to kill 90% of the germs on the surface and then pack the product under sterile conditions.
  • UV irradiation for sterilizing products is becoming increasingly important, since this method has many advantages over sterilization processes with peroxides or superheated steam.
  • the procedures are easy to apply, the product properties are not affected and the sterilization is very effective. No residue, no corrosive or harmful substances are produced during the treatment, the smell and taste of the food is not changed and the systems have low purchase and maintenance costs.
  • UVC rays are shorter wavelength and higher in energy than UVA and UVB rays. They cover most of the entire UV range and have a strong germicidal (bactericidal) effect. Like the visible wavelengths of light, UVC rays only move in a straight line and decrease in intensity as the distance from the source increases. UVC rays do not penetrate any substances, even window glass.
  • UVC radiation is technically produced by mercury lamps, whose primary radiation of 254nm, very close to the bactericidal effect maximum.
  • low, high or medium pressure lamps are used.
  • Low efficiency tubes with an efficiency of more than 90% in the bactericidal wavelength range are still unsurpassed in their efficiency.
  • the remaining radiation from a low-pressure tube is distributed to secondary emissions such as light (above 400nm) and heat.
  • UVC rays The germicidal effect of UVC rays is based on the following effects.
  • the short-wave and high-energy UVC rays are in certain areas of the DNA (DNA) is absorbed. This leads to a photo-chemical change in certain areas of the helix, for example to chain-linking reactions of adjacent functional groups. These become unusable for the copying process of the helix strand which works according to the template principle. The necessary information transfer is omitted. The cell can not multiply anymore.
  • the object of the invention was to provide an improved process for the production of germ-free, packaged products.
  • This object is achieved by a process for sterilizing products, wherein the products are wrapped with a packaging material and are irradiated in the packaged state with a UVC radiation, wherein the packaging material for UVC rays is permeable.
  • packaging materials have been found which, contrary to the prejudice in the prior art, are permeable to UVC radiation.
  • inventive method offers the extraordinary advantage that the products are sterilized in their packaging or together with the packaging material by means of UVC radiation. This virtually completely eliminates recontamination after sterilization of the products on the way to packaging.
  • a UVC permeability has been found for polymers of polylactic acid.
  • the packaging material may consist of an unstretched (cast film), a monoaxially oriented or a biaxially oriented polyhydroxycarboxylic acid film, which may have one or more layers.
  • Other suitable packaging forms are containers, trays or similar shapes.
  • the main component of these packaging materials is a polymer of at least one aliphatic hydroxycarboxylic acid.
  • the packaging material or the film contains at least 70-100% by weight of polymer of aliphatic polyhydroxycarboxylic acid, preferably PLA (polylactic acid).
  • Embodiments are preferred from 80-99 wt .-%, preferably 85-95 wt .-% of said polymers, each based on the weight of the packaging material.
  • Multilayer films are generally composed of a thick base layer which has the largest layer thickness and accounts for 60 to 100% of the total thickness of the film. This base layer is optionally provided on one side or both sides, with cover layer / s. In further embodiments, additional interlayers or coatings are possible on the outer surface of the monolayer or multilayer film to yield four- or five-layer, coated or uncoated, films.
  • the thickness of the cover layer is generally in a range of 0.5 to 20 .mu.m, preferably 0.5 to 10 .mu.m, in particular 1 to 5 .mu.m.
  • the total thickness of the film is according to the invention in a range of 20 to 100 .mu.m, preferably 25 to 150 .mu.m, in particular 30 to 100 .mu.m.
  • the cover layers are the layers which form the outer layers of the film. Interlayers are naturally applied between the base layer and the cover layers. The following remarks on the layers of the film apply mutatis mutandis in the same way for single-layer embodiments of the film.
  • the layer or layers of the film contains / contains from 70 to about 100% by weight, preferably 80 to 98 wt .-% of a polymer of at least one aliphatic hydroxycarboxylic, hereinafter also called PHC or polyhydroxycarboxylic acids.
  • PHC polyhydroxycarboxylic
  • polylactic acids are particularly suitable. These are hereinafter referred to as PLA (polylactidacide).
  • PLA polylactidacide
  • PLA polylactidacide
  • PLA aliphatic polyhydroxycarboxylic acid
  • monomers of the aliphatic polyhydroxycarboxylic acid (PHC) in particular aliphatic mono-, di- or trihydroxycarboxylic acids or their dimeric cyclic esters are suitable, among which lactic acid in its D or L form is preferred.
  • Such polymers are known per se in the art and are commercially available.
  • the production of polylactic acid is also described in the prior art and is carried out via catalytic ring-opening polymerization of lactide (1,4-dioxane-3,6-dimethyl-2,5-dione), the dimeric cyclic ester of lactic acid, therefore PLA is often also called polylactide designated.
  • lactide 1,4-dioxane-3,6-dimethyl-2,5-dione
  • polylactic acids which are composed exclusively of lactic acid units.
  • PLA homopolymers which contain 80-100% by weight of L-lactic acid units, corresponding to 0 to 20% by weight of D-lactic acid units, are preferred.
  • D-lactic acid units can be included as a comonomer.
  • the polylactic acid may additionally comprise aliphatic polyhydroxycarboxylic acid units other than lactic acid as comonomer, for example glycolic acid units, 3-hydroxypropanoic acid units, 2,2-dimethyl-3-hydroxypropanic acid units or higher homologs of hydroxycarboxylic acids having up to 5 carbon atoms.
  • the molecular weight of the PLA is in a range of at least 10,000 to 500,000 (number average), preferably 50,000 to 300,000 (number average).
  • the glass transition temperature Tg is in a range from 40 to 100.degree. C., preferably from 40 to 80.degree.
  • the individual layers of the film each contain 70 to about 100 wt .-% of the polymers described above, preferably 80 to 98 wt .-%, and optionally additionally additives such as neutralizing agents, stabilizers, lubricants, antistatic agents and other additives, provided that the UVC Do not obstruct permeability. They are expediently added to the polymer or the polymer mixture before melting. Stabilizers used are, for example, phosphorus compounds, such as phosphoric acid or phosphoric acid esters. In principle, the individual layers may have the same or different composition / s with regard to polymer and additization. In general, the composition of the base layer will be different from the composition of the remaining layers. In particular, additives such as antiblocking agents or lubricants are added to the outer layers. Neutralizers and stabilizers are generally present in all layers in respective effective amounts. However, the structure and composition of the individual layers of the film can fundamentally vary within wide limits.
  • the film can be coated to optimize other properties.
  • These coatings may be based on the above-described PHC polymers or, in turn, should be transparent to UVC radiation.
  • Typical coatings are adhesion-promoting, slip-improving or dehesive layers.
  • these additional layers may be over-lined by means of aqueous or nonaqueous dispersions prior to cross-stretching or applied off-line.
  • the PHC film is produced by the extrusion or coextrusion process known per se.
  • the melt (s) corresponding to the layers of the film are coextruded through a flat die, and the single or multilayer film thus obtained is drawn off on one or more rolls for solidification.
  • the film is then mono- or biaxially stretched (oriented), the stretched film heat-set.
  • the films on the surface layer provided for the treatment on one or both sides corona or flame treated.
  • the stretching in the longitudinal direction preferably takes place with the aid of two rolls running at different speeds in accordance with the desired stretch ratio. For cross-stretching you generally use a corresponding clip frame.
  • the biaxial orientation can also be simultaneously carried out for example by means LISIM ® technology.
  • the further description of the film production takes place using the example of a flat film extrusion with subsequent sequential stretching.
  • the melt / n are pressed through a flat die (slot die), and the extruded film is taken off on one or more take-off rolls at a temperature of 10 to 1OfJ 0 C, preferably 20 to 80 0 C, during which it cools and solidifies.
  • the film thus obtained is then stretched longitudinally and transversely to the extrusion direction.
  • the longitudinal stretching is preferably run at a roll temperature of the draw rolls from 40 to 130 0 C, preferably 50 to 100 0 C expediently throughput by means of two corresponding to the desired stretching ratio, running at different speeds rollers and the transverse stretching is preferably performed at a temperature of 50 to 130 0 C, preferably 60 to 120 0 C using a corresponding clip frame.
  • the Longitudinal stretching ratios can be varied in the range of 1.5 to 8, preferably 1.5 to 4.
  • the transverse stretching ratios are in the range of 3 to 10, preferably 4 to 7.
  • the stretching of the film is followed by its heat setting (heat treatment), wherein the film is held convergently for about 0.1 to 10 s at a temperature of 60 to 150 0 C (convergence up to 25%). Subsequently, the film is wound in the usual manner with a winding device.
  • containers, bowls, bottles or other forms are suitable. These containers are made from the above-described polyhydroxycarboxylic acids, preferably PLA, as described above in connection with the films.
  • the rheological properties of the polymer must be adapted to the particular processing method, for example, the manufacture of injection molded or blow molded containers requires a different melt flow index of the PLA as a film raw material.
  • the suitable raw materials from the PLA polymers known per se.
  • any conventional packaging technologies and filling processes may be used, for example film wrapping on HFFS or VFFS packing machines.
  • the sterilization according to the invention partial sterilization or sterilization by UV radiation takes place.
  • the packaged product is suitably exposed in the package to UV radiation comprising the wavelength range of 254 nm (UVC).
  • UV radiation comprising the wavelength range of 254 nm (UVC).
  • UV-C radiation is produced technically by mercury lamps, for example by low-pressure lamps, optionally also by high or medium pressure lamps.
  • the UV lamps generally consist of a housing with a quartz glass window as an exit window for the radiation and the actual mercury discharge lamp.
  • Low-pressure tubes are preferred because they are very effective with a very high efficiency of over 80% in the bactericidal wavelength range of about 254nm.
  • these lamps also emit radiation at other wavelengths, for example in the range of 200 to 280 nm, but have the relevant range from about 254nm the highest intensity.
  • high-performance low-pressure mercury lamps are used, which are provided with a cooling device. The cooling prevents heating and the associated shift in the spectrum. These lamps are characterized by a very high and constant power outputs.
  • the radiant power of the UV lamps used can basically vary within a wide range, for example between 50 and 250W 1, preferably between 100 and 150W.
  • a ballast can be used to power, control and monitor the operating parameters. The irradiance can be adjusted individually to the respective sterilization or degermination process, or the contents.
  • the irradiance indicates the radiation power per area and is for example 10 to 200 mW / cm 2 , preferably 50 to 150 mW / cm 2 .
  • the speed of the band can be used to regulate the irradiation time and thus the irradiation dose.
  • the metering can also be effected via corresponding filters which influence the transmission of the UV radiation produced.
  • all three parameters should be set and optimized for the best possible efficiency.
  • the irradiation dose can be adjusted both on the irradiation time and on the irradiance.
  • the contents can also be pre-cleaned by per se known processes, or be sterilized in advance and subsequently treated by means of the sterilization or sterilization process according to the invention.
  • all types of filling products can be sterilized or sterilized by means of the process according to the invention, for example piece goods, products, powders, grains, liquids and water, for example packaged in bottles.
  • the products are all products in which sterilization and sterile storage is required, such as food, other perishables, medical products, such as disposable syringes dressing material or implants.
  • the method according to the invention makes use of all advantages of the UV sterilization or UV sterilization known per se and avoids recontamination of the products on the way from the sterilization to packaging, or until the intended use, since the packaging after sterilization before said recontamination reliably protects.
  • This sanitizing system is thus extremely effective and easy to use.
  • the product properties are not affected and no residues, side effects or by-products are produced.
  • the process leads in a single step to a germ-free packaged good, which ensures the quality and shelf life in the easiest way.
  • the packaging according to the invention will not be provided with a print or other applications which could hinder the passage of the UV radiation.
  • small-area imprints such as Data or
  • Umverpackung or labels are provided, which in turn has decorative or informative elements / s, for example, wrap-around labels, self-adhesive labels, a whole or partial area printing or a metal layer for protection against gas or
  • This outer packaging must meet no special requirements in terms of sterility and can therefore be selected depending on the application of the variety of packaging materials known per se for functionality or appearance.
  • the base layer was nearly 100% by weight of a polylactic acid with a melting point of about 160 0 C.
  • the layer additionally contained stabilizers and neutralizing agents in conventional amounts.
  • the two sealable outer layers were essentially composed of an amorphous polylactic acid, this polylactic acid having an L / D ratio of about 40/60.
  • the cover layers each contained 0.1% by weight of SiO 2 -based particles as antiblocking agents. The thickness of the cover layers was 2.5 ⁇ m in each case.
  • a bag package was made.
  • the pouch packaging was filled with strawberries and sealed. Subsequently, the filled, sealed by sealing seams package was placed under a low pressure mercury lamp for 30 sec and then stored at a temperature of about 10 0 C for 7 days.
  • a bag packaging was prepared.
  • the pouch packaging was filled with strawberries and sealed.
  • the packaging was stored without previous UV disinfection at a temperature of about 10 ° C for 7 days.
  • Transverse direction produced a transparent three-layer polypropylene film with symmetrical structure with a total thickness of 20 microns.
  • the cover layers had one
  • the base layer was made of propylene homopolymer with a Melting point of 166 0 C and a melt flow index of 3.4 g / 10min and N, N-bis-ethoxyalkylamine as an antistatic agent.
  • the outer layers consisted of random ethylene-propylene copolymers having a C 2 content of 4.5% by weight and 0.33% by weight of SiO 2 as antiblocking agent with an average particle size of 2 ⁇ m and 0.90% by weight. % Polydimethylsiloxane.
  • a bag package was made.
  • the pouch packaging was filled with strawberries and sealed. Subsequently, the filled, closed by sealing seams package was placed under a low pressure mercury lamp for 30 sec and stored at a temperature of about 10 0 C for 7 days.
  • Example 3 the strawberries which were packed according to Example 1 and UV-sterilized showed no signs of decay or mold, whereas without UV sterilization (Example 2) or with oPP film despite UV sterilization (Example 3) significant spoilage traces were observed.

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Wrappers (AREA)
  • Packages (AREA)

Abstract

La présente invention concerne un procédé pour la stérilisation de produits par rayonnement UV. Un produit est tout d'abord enveloppé d'un matériau d'emballage transparent aux UV en acide polyhydroxycarboxylique, puis stérilisé dans l'état emballé par irradiation de rayonnement UV.
EP08716505A 2007-03-16 2008-03-13 Emballage pour la sterilisation par uv Not-in-force EP2139777B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007012623 2007-03-16
PCT/EP2008/002008 WO2008113509A1 (fr) 2007-03-16 2008-03-13 Emballage pour la stérilisation par uv

Publications (2)

Publication Number Publication Date
EP2139777A1 true EP2139777A1 (fr) 2010-01-06
EP2139777B1 EP2139777B1 (fr) 2012-09-26

Family

ID=39432501

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08716505A Not-in-force EP2139777B1 (fr) 2007-03-16 2008-03-13 Emballage pour la sterilisation par uv

Country Status (5)

Country Link
US (1) US9309018B2 (fr)
EP (1) EP2139777B1 (fr)
CA (1) CA2680082C (fr)
ES (1) ES2397873T3 (fr)
WO (1) WO2008113509A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022121420A1 (fr) * 2020-12-09 2022-06-16 华南农业大学 Synergiste de stérilisation aux ultraviolets et procédé de stérilisation utilisant celui-ci en combinaison avec des ultraviolets

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112124A (en) 1971-04-26 1978-09-05 Drisan Packaging Ltd. Food packaging system and method
CH572415A5 (fr) * 1974-04-10 1976-02-13 Aluminiumwerke Ag Rorschach
DE3545116A1 (de) 1985-05-17 1986-11-20 Transaktor KB International, Göteborg Flasche fuer wassernotverpflegung und verfahren zur herstellung einer flasche mit wassernotverpflegung
JPH0797957B2 (ja) 1988-08-29 1995-10-25 呉羽化学工業株式会社 真空包装生肉の殺菌方法
US5208297A (en) 1991-12-30 1993-05-04 E. I. Du Pont De Nemours And Company Rare earth metal coordination compounds as lactone polymerization catalysts
US5247058A (en) 1992-01-24 1993-09-21 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5142023A (en) 1992-01-24 1992-08-25 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5326542A (en) * 1992-10-01 1994-07-05 Tetra Laval Holdings & Finance S.A. Method and apparatus for sterilizing cartons
US5489022A (en) 1994-04-19 1996-02-06 Sabin Corporation Ultraviolet light absorbing and transparent packaging laminate
US5817728A (en) * 1995-03-16 1998-10-06 Mitsui Chemicals, Inc. Preparation of degradable copolymers
US6433344B1 (en) * 1996-05-22 2002-08-13 Purepulse Technologies, Inc. Pulsed light sterilization of drinking water and drinking water containers
US5914381A (en) * 1996-09-12 1999-06-22 Mitsui Chemicals, Inc. Degradable polymer and preparation process of the same
DE19880351T1 (de) * 1997-02-19 1999-04-08 Nippon Foil Mfg Co Verpackungsmaterial und -behälter
FR2773715A1 (fr) 1998-01-20 1999-07-23 Becton Dickinson France Procede d'introduction d'objets conditionnes dans une zone sterile
CN1130411C (zh) * 1999-06-22 2003-12-10 三井化学株式会社 制备聚羟基羧酸的方法
PL363006A1 (en) * 2000-10-26 2004-11-15 Atlantium Lasers Limited Disinfection through packaging
ES2244803T3 (es) * 2001-04-30 2005-12-16 TREOFAN GERMANY GMBH & CO.KG Pelicula de acido polilactico con buenas propiedades antiestaticas.
DE60216029T2 (de) * 2001-09-26 2007-06-21 Kabushiki Kaisha Toshiba Copolymer-Harzzusammensetzung und Verfahren zu seiner Herstellung
US7329792B2 (en) * 2003-02-04 2008-02-12 Damage Control Surgical Technologies, Inc. Method and apparatus for hemostasis
US8231590B2 (en) * 2003-12-30 2012-07-31 Kimberly-Clark Worldwide, Inc. Visually coordinated absorbent product
JP4495535B2 (ja) * 2004-07-22 2010-07-07 東セロ株式会社 ポリ乳酸二軸延伸積層フィルム及びその用途
US20070051653A1 (en) * 2005-09-08 2007-03-08 Tilton Christopher R Reusable packaging

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008113509A1 *

Also Published As

Publication number Publication date
CA2680082A1 (fr) 2008-09-25
EP2139777B1 (fr) 2012-09-26
US20100092627A1 (en) 2010-04-15
ES2397873T3 (es) 2013-03-12
CA2680082C (fr) 2016-06-14
US9309018B2 (en) 2016-04-12
WO2008113509A1 (fr) 2008-09-25

Similar Documents

Publication Publication Date Title
EP3356115B1 (fr) Procédé pour réduire la charge microbiologique de produits du type contenant
DE69425838T2 (de) Nicht-oxydierendes, medizinisches Polymerimplantat
DE60002015T2 (de) Tieftemperatur-Druckstabilisation von Implantkomponenten
DE3689695T2 (de) Vorrichtung und verfahren zur aseptischen verpackung von nahrungsmitteln.
DE69424531T2 (de) Im autoklaven behandelbare mehrsschichtfilme
DE60129597T2 (de) Verfahren zur verbesserung der stabilität einer pharmazeutischen zubereitung
DE69712207T2 (de) Verfahren und Vorrichtung zum Sterilisieren von Packstoffbahnen
DE102008037898B4 (de) Verfahren und Vorrichtung zur Sterilisation von Verpackungsmaterial und/oder Behältern, diesbezügliche Verwendung von Plasma sowie entsprechend behandeltes Material oder Behälter
EP2029043A1 (fr) Emballage stérilisé, son procédé de fabrication et son utilisation en médecine
EP2139777B1 (fr) Emballage pour la sterilisation par uv
EP3079993B1 (fr) Procédé d'aseptisation de moyens d'emballage
EP1028994A1 (fr) Materiau d'emballage sous forme de film
Farousha et al. The future of food preservation: active packaging with controlled release systems
EP2482858A1 (fr) Procédé et dispositif de stérilisation de surfaces
EP1500595B1 (fr) Procede pour preserver les produits alimentaires conserves dans leur emballage de la deterioration et emballage ou semi-produit pour emballage destine a la conservation de produits alimentaires
CN109846745A (zh) 一种无菌无添加表皮修护精华液及其制备方法
DE102004042968A1 (de) Schrumpfbare Mehrschichtfolie mit lösbarer Produkthaftung
EP0402922B1 (fr) Procédé pour la stériliation de matérieaux chirurgicaux
EP1864909A1 (fr) Emballage en cyanoacrylate stérilisé
DE102012010155B4 (de) Zellkulturbehälter für den Einmalgebrauch
Panickar et al. Cold Plasma Technology Based Eco-friendly food packaging biomaterials
WO2002055301A1 (fr) Feuille polyester multicouche a garniture anti-microbienne et surface matte
CH442736A (de) Antibakteriell ausgerüstetes Material und Verfahren zu seiner Herstellung
EP1144507A2 (fr) Corps extrudes thermoplastiques biodegradables presentant une stabilite a l'hydrolyse et une resistance au fendillement par contrainte ameliorees
Al-Tayyar Development of Eco-friendly Antimicrobial Food-Grade Packaging Materials Using Bionanocomposite Films

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091016

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20110308

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WALGENBACH, DIRK

Inventor name: BUSCH, DETLEF

Inventor name: SCHMITZ, BERTRAM

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 576914

Country of ref document: AT

Kind code of ref document: T

Effective date: 20121015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502008008258

Country of ref document: DE

Effective date: 20121122

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121226

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

Effective date: 20120926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121227

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2397873

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20130312

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 502008008258

Country of ref document: DE

Representative=s name: ,

Ref country code: DE

Ref legal event code: R082

Ref document number: 502008008258

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130128

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121226

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E016225

Country of ref document: HU

26N No opposition filed

Effective date: 20130627

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502008008258

Country of ref document: DE

Effective date: 20130627

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120926

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20200325

Year of fee payment: 13

Ref country code: IE

Payment date: 20200323

Year of fee payment: 13

Ref country code: AT

Payment date: 20200319

Year of fee payment: 13

Ref country code: HU

Payment date: 20200303

Year of fee payment: 13

Ref country code: IT

Payment date: 20200325

Year of fee payment: 13

Ref country code: DE

Payment date: 20200320

Year of fee payment: 13

Ref country code: NL

Payment date: 20200323

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20200323

Year of fee payment: 13

Ref country code: CH

Payment date: 20200325

Year of fee payment: 13

Ref country code: BE

Payment date: 20200323

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20200324

Year of fee payment: 13

Ref country code: TR

Payment date: 20200313

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20200421

Year of fee payment: 13

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 502008008258

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20210401

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 576914

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210313

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20210313

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210401

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210313

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210331

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210313

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210331

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211001

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210331

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210313

Ref country code: HU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210314

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210313

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210313

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20220523

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210314

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210313